Swedbank AB Takes Position in BridgeBio Pharma, Inc. $BBIO
MarketBeat
Swedbank AB bought a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 27,600 shares of the company's stock, valued at approximately $2,111,000. Several othe
NASDAQ:BBIO